168 related articles for article (PubMed ID: 3342460)
1. Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat.
Greig NH; Sweeney DJ; Rapoport SI
Cancer Chemother Pharmacol; 1988; 21(1):1-8. PubMed ID: 3342460
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of chlorambucil-tertiary butyl ester, a lipophilic chlorambucil derivative that achieves and maintains high concentrations in brain.
Greig NH; Daly EM; Sweeney DJ; Rapoport SI
Cancer Chemother Pharmacol; 1990; 25(5):320-5. PubMed ID: 2306791
[TBL] [Abstract][Full Text] [Related]
3. Development of lipophilic anticancer agents for the treatment of brain tumors by the esterification of water-soluble chlorambucil.
Genka S; Deutsch J; Shetty UH; Stahle PL; John V; Lieberburg IM; Ali-Osman F; Rapoport SI; Greig NH
Clin Exp Metastasis; 1993 Mar; 11(2):131-40. PubMed ID: 8444006
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical and pharmacokinetic parameters of seven lipophilic chlorambucil esters designed for brain penetration.
Greig NH; Genka S; Daly EM; Sweeney DJ; Rapoport SI
Cancer Chemother Pharmacol; 1990; 25(5):311-9. PubMed ID: 2306790
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacokinetics of chlorambucil and melphalan in man.
Alberts DS; Chang SY; Chen HS; Larcom BJ; Evans TL
Recent Results Cancer Res; 1980; 74():124-31. PubMed ID: 7444135
[TBL] [Abstract][Full Text] [Related]
6. Studies on the pharmacokinetics of chlorambucil and prednimustine in patients using a new high-performance liquid chromatographic assay.
Oppitz MM; Musch E; Malek M; Rüb HP; von Unruh GE; Loos U; Mühlenbruch B
Cancer Chemother Pharmacol; 1989; 23(4):208-12. PubMed ID: 2924378
[TBL] [Abstract][Full Text] [Related]
7. Brain and plasma pharmacokinetics and anticancer activities of cyclophosphamide and phosphoramide mustard in the rat.
Genka S; Deutsch J; Stahle PL; Shetty UH; John V; Robinson C; Rapoport SI; Greig NH
Cancer Chemother Pharmacol; 1990; 27(1):1-7. PubMed ID: 2245487
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic basis for the comparative antitumour activity and toxicity of chlorambucil, phenylacetic acid mustard and beta, beta-difluorochlorambucil (CB 7103) in mice.
Lee FY; Coe P; Workman P
Cancer Chemother Pharmacol; 1986; 17(1):21-9. PubMed ID: 3698173
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetics of chlorambucil and prednimustine after oral administration.
Loos U; Musch E; Malek M; Riedel E
Oncology; 1991; 48(4):334-42. PubMed ID: 1891177
[TBL] [Abstract][Full Text] [Related]
10. High-performance liquid chromatographic analysis of chlorambucil tert.-butyl ester and its active metabolites chlorambucil and phenylacetic mustard in plasma and tissue.
Greig NH; Stahle PL; Shetty HU; Genka S; John V; Soncrant TT; Rapoport SI
J Chromatogr; 1990 Dec; 534():279-86. PubMed ID: 2094719
[No Abstract] [Full Text] [Related]
11. Pharmacokinetics of chlorambucil in patients with chronic lymphocytic leukaemia: comparison of different days, cycles and doses.
Silvennoinen R; Malminiemi K; Malminiemi O; Seppälä E; Vilpo J
Pharmacol Toxicol; 2000 Nov; 87(5):223-8. PubMed ID: 11129502
[TBL] [Abstract][Full Text] [Related]
12. Facilitated transport of melphalan at the rat blood-brain barrier by the large neutral amino acid carrier system.
Greig NH; Momma S; Sweeney DJ; Smith QR; Rapoport SI
Cancer Res; 1987 Mar; 47(6):1571-6. PubMed ID: 3815357
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice.
Nath K; Nelson DS; Putt ME; Leeper DB; Garman B; Nathanson KL; Glickson JD
PLoS One; 2016; 11(6):e0157125. PubMed ID: 27285585
[TBL] [Abstract][Full Text] [Related]
14. Concentration and time-dependent inter-relationships for cytotoxicities of nitrogen mustard drugs against lymphoblasts in-vitro.
Ehrsson H; Wallin I; Ringborg U
J Pharm Pharmacol; 1988 Dec; 40(12):834-7. PubMed ID: 2907574
[TBL] [Abstract][Full Text] [Related]
15. The effect of dietary amino acids on the gastrointestinal absorption of melphalan and chlorambucil.
Adair CG; McElnay JC
Cancer Chemother Pharmacol; 1987; 19(4):343-6. PubMed ID: 3594717
[TBL] [Abstract][Full Text] [Related]
16. The metabolism of deuterated analogues of chlorambucil by the rat.
Farmer PB; Foster AB; Jarman M; Newell DR; Oddy MR; Kiburis JH
Chem Biol Interact; 1979 Dec; 28(2-3):211-24. PubMed ID: 549741
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of chlorambucil in vitro: effects of fluid matrix, human gastric juice, plasma proteins and red cells.
Löf K; Hovinen J; Reinikainen P; Vilpo LM; Seppälä E; Vilpo JA
Chem Biol Interact; 1997 Mar; 103(3):187-98. PubMed ID: 9134009
[TBL] [Abstract][Full Text] [Related]
18. Melphalan penetration of the blood-brain barrier via the neutral amino acid transporter in tumor-bearing brain.
Cornford EM; Young D; Paxton JW; Finlay GJ; Wilson WR; Pardridge WM
Cancer Res; 1992 Jan; 52(1):138-43. PubMed ID: 1727374
[TBL] [Abstract][Full Text] [Related]
19. Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity.
Alaoui-Jamali MA; Panasci L; Centurioni GM; Schecter R; Lehnert S; Batist G
Cancer Chemother Pharmacol; 1992; 30(5):341-7. PubMed ID: 1505071
[TBL] [Abstract][Full Text] [Related]
20. Aneugenic potential of the nitrogen mustard analogues melphalan, chlorambucil and p-N,N-bis(2-chloroethyl)aminophenylacetic acid in cell cultures in vitro.
Efthimiou M; Andrianopoulos C; Stephanou G; Demopoulos NA; Nikolaropoulos SS
Mutat Res; 2007 Apr; 617(1-2):125-37. PubMed ID: 17324445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
